NCT00084734View on ClinicalTrials.gov

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

capecitabine

Oral

DRUG

cisplatin

IV

DRUG

docetaxel

IV

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00084734 - Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter